[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ureteral-stones-kidney-stones\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ureteral-stones-kidney-stones":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100053645","stone-and-laser-therapies-post-market-study-salt-100053645",false,"NCT06982235","Stone and Laser Therapies Post-Market Study (SALT)","Stone and Laser Therapies Post-Market Study","SALT","Inclusion Criteria:\n\nFor urinary tract procedure cohort:\n\n1. Subject intends to undergo diagnostic and\u002For therapeutic urinary tract procedure with qualified BSC device(s)\n2. Subject is willing and able to complete all follow-up visits\n\nFor BPH cohort:\n\n1. Subject is ≥ 40 years of age\n2. Subject with a diagnosis of benign prostatic hyperplasia (BPH) with lower urinary tract symptoms\n3. Subject intends to undergo BPH treatment with qualified BSC device(s)\n4. Subject is willing and able to complete all follow-up visits\n\nExclusion Criteria:\n\nFor urinary tract procedure cohort:\n\n1. Subject requires simultaneous surgical treatment for BPH\n2. Unwilling or unable to provide consent\n3. Any other condition which, in the opinion of the investigator, precludes study participation (e.g., history of medical non-compliance, etc.)\n\nFor BPH cohort:\n\n1. Subject requires simultaneous upper urinary calculi lithotripsy procedure (not applicable to bladder calculi)\n2. Unwilling or unable to provide consent\n3. Any other condition which, in the opinion of the investigator, precludes study participation (e.g., history of medical non-compliance, etc.)","ALL",{"count":19,"type":20},238,"ESTIMATED","12 Months","OBSERVATIONAL","The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and\u002For therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.",[25,26,27,28,29],"Benign Prostate Hypertrophy(BPH)","Renal Calculi","Ureteral Stones, Kidney Stones","Calculi, Urinary","Urinary Tract Procedure",[31,32,33,26,34,35,36,29],"BPH","Benign Prostatic Hyperplasia","Lithotripsy","Renal Calculus","Boston Scientific","Kidney Stone","RECRUITING","2026-07-10",{"date":40,"type":41},"2026-07-13","ACTUAL",{"date":43,"type":41},"2025-06-30",{"date":45,"type":20},"2029-02",{"name":47,"class":48},"Boston Scientific Corporation","INDUSTRY",5,{"id":51,"slug":4,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":52,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":53,"keywords":54,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":59,"leadSponsor":60,"locationsCount":49},"100591577",{"count":19,"type":20},[25,26,27,28,29],[31,32,33,26,34,35,36,29],"2026-06-11",{"date":57,"type":41},"2026-06-12",{"date":43,"type":41},{"date":45,"type":20},{"name":47,"class":48}]